Date:May 14, 2012

Amber Yates, MD

Amber Yates, MDAssistant Director, Clinical Division (Outpatient)
Texas Children’s Cancer and Hematology Centers

Co-Director, Sickle Cell Program
Texas Children’s Cancer and Hematology Centers

Assistant Professor
Department of Pediatrics
Section of Hematology-Oncology
Baylor College of Medicine

Dr. Amber Yates
Texas Children’s Cancer and Hematology Centers
6701 Fannin Street, Suite 1580
Houston, TX 77030

Phone: 832-822-4502
Fax: 832-825-1503

About Dr. Amber Yates

Dr. Amber Yates is Assistant Director of the Clinical Division where she oversees outpatient care. She is also Co-Director of the Sickle Cell Program and a member of the Hematology Center.

Her primary clinical interest is in the care of children with sickle cell disease and other hemoglobin disorders. She is particularly interested in the role of hydroxyurea therapy in improving the lives of children with sickle cell disease, as well as the long term safety and efficacy of hydroxyurea.

Dr. Amber Yates is also interested in assisting teenage patients with hematologic disorders so they can achieve a successful transition to adult care.

In 2017, Yates was selected for a three-year term as a content expert for the American Academy of Pediatrics/American Society of Pediatric Hematology-Oncology Policy Review Work Group in the area of nonmalignant hematology. This collaborative group strengthens the pediatric hematology-oncology member voice and level of engagement and involvement in the AAP and helps develop joint policy statements and clinical reports.


M.D., Louisiana State University Health Sciences Center, Shreveport, LA
Pediatric Residency, University of Tennessee Health Sciences Center, Memphis, TN
Pediatric Hematology-Oncology Fellowship, St. Jude Children’s Research Hospital, Memphis, TN

Board Certifications

American Board of Pediatrics
American Board of Pediatrics – Hematology/Oncology

Selected Memberships

Member, American Academy of Pediatrics (AAP)
Member, American Society of Hematology (ASH)
Member, American Society of Pediatric Hematology/Oncology (ASPHO)

Clinical Special Interests

Hemolytic Anemia
Sickle Cell Disease
Adolescent transition to adult care

Research Interests

Hydroxyurea therapy